Third Party Viral Specific T-cells (VSTs)

计划入组 1,000 人 · 首次发布于 2015 年 8 月 25 日

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

首次发布于 2014 年 10 月 24 日

The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients

计划入组 64 人 · 首次发布于 2016 年 2 月 1 日

Chinese cinnamon

Nardostachys chinensis whole

Anti-CD19/22-CAR vector-transduced T cell therapy (Chinese PLA General Hospital)

European Lung Cancer Working Party

Belgium

Chinese Medical Association

China

THE EGYPTIAN CHINESE UNIVERSITY

Egypt

FDA Asked to Scrutinize US Pharma's Clinical Trials with PLA Affiliates

FDA Halts Clinical Trials Sending American Cells to Foreign Labs for Genetic Engineering

Web of Biological Data Act: Bipartisan Bill Seeks to Centralize U.S. Biological Data to Accelerate Biotech Innovation